31.03.2015 01:03:00

ARKEMA FILES ITS 2014 REFERENCE DOCUMENT

Regulatory News:

Arkema (Paris:AKE) announces that it released its 2014 Reference document, filed with the French Autorité des marchés financiers (AMF) on 30 March 2015 with visa number D.15-0231.

This document is available under the heading Investor Relations in section Annual reports of the Group’s website under the following link: www.finance.arkema.com.

Among others, the following documents are included in the 2014 Reference document:

- the 2014 annual financial report,

- the management report of the Board of Directors,

- the report of the Chairman of the Board of Directors on the conditions for preparing and organizing the Board of Directors’ activities and the internal control and risk management procedures as well as the statutory auditors’ report in accordance with article L.225-235 of the French Commercial Code (Code de commerce) on said Chairman’s report,

- the details of the fees paid to the statutory auditors, and

- the agenda and the draft resolutions proposed to the Combined Annual General Meeting on 2 June 2015, among which the elements of compensation due or allocated for 2014 to each of the Company’s executive officers submitted to shareholders’ opinion.

A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in close to 50 countries, some 19,000 employees and research centers in North America, France and Asia, Arkema generates pro forma annual revenue of some €7.6 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.

ARKEMA
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex – France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 728 226 950 euros – 445 074 685 RCS Nanterre
arkema.com

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 75,05 1,62% ArkemaAct.